This article was originally published in The Rose Sheet
Executive SummaryUpswing in sales on beauty.com in the last two quarters indicates that consumers are migrating back to prestige beauty, says Drugstore.com VP and CFO Tracy Wright. Speaking at the Janney Capital Markets Consumer Conference May 26, Wright noted that during the recession, many consumers of premium items online switched to mass market items sold through sites like drugstore.com, but that trend has reversed in recent quarters. In February, the Bellevue, Wash.-based firm reported that beauty.com's net revenues advanced 28 percent in the fourth quarter (1"The Rose Sheet" Feb. 15, 2010). Drugstore.com's total prestige product business amounts to about $30 million. The company recently announced the launch of two new microsites - AllergySuperstore.com and TheNaturalStore.com - which both sell beauty products targeted to the specific needs of the sites' shoppers. The firm announced the launch of another microsite, DeluxeSalonSupply.com, May 10 (2"The Rose Sheet" May 17, 2010)
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.